Clonal heterogeneity in mycosis fungoides and its relationship to clinical course.

Mycosis fungoides (MF) is a cutaneous T-cell lymphoma characterized by multifocal disease and protracted clinical course. The few studies that have assessed T-cell receptor (TCR) gene rearrangements (GRs) present at different anatomic sites in MF have generally reported a common clone. We used a previously validated 4-color polymerase chain reaction (PCR) assay to assess the size and V-family usage of TCR-gamma GRs in 102 concurrent and/or sequential morphologically involved biopsy specimens (91 skin and 11 lymph nodes) from 39 MF patients. This assay detected TCR-gamma clonal GRs in 89 samples (87%) from 36 patients (92%). In 24 patients (77%), an identical clonal GR was present in at least 2 skin samples. However, in one third of these patients, additional different clonal GRs were also noted. Four patients (13%) had clonal GRs that were distinct in different skin samples. In 3 patients (10%), no GR was detected in any sample. In a comparison of lymph node and skin samples, 8 patients had the identical clonal GRs at both sites, 2 patients had different clonal GRs, and 1 patient had no GR identified at either site. Independent of clinical stage, patients who had the same GR detected in multiple concurrent biopsy specimens at the time of diagnosis were more likely to have progressive disease than those who had different GRs (P =.04). Four-color TCR-gamma PCR analysis can uncover multiple distinct clonal GRs in different samples consistent with multiclonal or oligoclonal disease in a significant proportion of MF patients. Demonstration of identical clonal GRs in multiple biopsy specimens at the time of diagnosis may provide prognostic information related to disease progression.

[1]  J. Manning,et al.  A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions. , 2001, American journal of clinical pathology.

[2]  É. Lepage,et al.  Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. , 2000, Blood.

[3]  J. Muche,et al.  Peripheral blood T cell clonality in mycosis fungoides -an independent prognostic marker? , 2000, The Journal of investigative dermatology.

[4]  M. Loda,et al.  Detection of TCR‐γ gene rearrangements in early mycosis fungoides by non‐radioactive PCR‐SSCP , 2000 .

[5]  H. Muller-Hermelink,et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  H. Stein,et al.  Clonal T‐cell receptor γ‐chain gene rearrangement by PCR‐based GeneScan analysis in advanced cutaneous T‐cell lymphoma: a critical evaluation , 1999, The Journal of pathology.

[7]  J. Taubenberger,et al.  Enhanced sensitivity with a novel TCRgamma PCR assay for clonality studies in 569 formalin-fixed, paraffin-embedded (FFPE) cases. , 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[8]  T. Petrella,et al.  Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. , 1998, Blood.

[9]  T. Petrella,et al.  Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow‐up of patients with mycosis fungoides , 1998, The Journal of pathology.

[10]  G. Wood.  Using molecular biologic analysis of T-cell receptor gene rearrangements to stage cutaneous T-cell lymphoma. , 1998, Archives of dermatology.

[11]  K. Asadullah,et al.  Demonstration of Frequent Occurrence of Clonal T Cells in the Peripheral Blood of Patients With Primary Cutaneous T-Cell Lymphoma , 1997 .

[12]  K. McCarthy,et al.  The polymerase chain reaction in the diagnosis of early mycosis fungoides , 1997, The Journal of pathology.

[13]  A. Oseroff,et al.  Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. , 1997, Journal of the American Academy of Dermatology.

[14]  M. Bagot,et al.  Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. , 1995, Blood.

[15]  J. Buer,et al.  Conformational polymorphisms of cRNA of T-cell-receptor genes as a clone-specific molecular marker for cutaneous lymphoma. , 1993, The Journal of investigative dermatology.

[16]  Y. Bignon,et al.  Genotyping of cutaneous T-cell lymphomas and pseudolymphomas. , 1989, Current problems in dermatology.

[17]  J. Sklar,et al.  Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome. , 1989, The Journal of investigative dermatology.

[18]  P. Bunn,et al.  Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. , 1979, Cancer treatment reports.

[19]  J. Musser,et al.  Association of Erythrodermic Cutaneous T-Cell Lymphoma, Superantigen-Positive Staphylococcus aureus, and Oligoclonal T-Cell Receptor Vβ Gene Expansion , 1997 .

[20]  M. Tiemann,et al.  Temperature gradient gel electrophoresis for analysis of a polymerase chain reaction‐based diagnostic clonality assay in the early stages of cutaneous T‐cell lymphomas , 1995, Electrophoresis.